SK

Sanjay Koul

Active Director Director DIN 09315162
DIN 09315162 First appointment Sep 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Sanjay Koul

Data last updated:

Sanjay Koul is a Director at Bradina Aaronalis Pharmaceuticals Private Limited (since 2021). The company operates in Healthcare. Bradina Aaronalis Pharmaceuticals Private Limited reported revenue of ₹91.8 Lakh (FY 2024).

DIN 09315162
Primary Designation Director
Industry Healthcare
First Appointment 11 Sep 2021
Oldest Company Age 5 yrs
Largest company Bradina Aaronalis Pharmaceuticals Private Limited · ₹91.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Sep 20212021₹91.8 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Bradina Aaronalis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sanjay Koul

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Koul

Sanjay Koul currently holds 1 directorship: Bradina Aaronalis Pharmaceuticals Private Limited (Director, since 11 Sep 2021, revenue ₹91.8 Lakh (FY 2024)).

Sanjay Koul was first appointed on 11 Sep 2021 as Director at Bradina Aaronalis Pharmaceuticals Private Limited.

The current boards of Sanjay Koul's companies include Amrinder Singh (Bradina Aaronalis Pharmaceuticals Private Limited), Pardeep Singh (Bradina Aaronalis Pharmaceuticals Private Limited), Varinder Kumar (Bradina Aaronalis Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available